Lasa Supergenerics Ltd - ESG Rating & Company Profile powered by AI
This Disclosure rating includes seventeen United Nations SDGs including: 'Good Health & Wellbeing', 'Climate Action' and 'Partnerships for the Goals'. This SDG rating for Lasa Supergenerics Ltd indicates its transparency towards the UN SDGs. If you are employed by Lasa Supergenerics Ltd and you wish to licence your ESG aseessment, please get in touch.
Lasa Supergenerics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 5.3 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | Lasa Supergenerics Ltd | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Lasa Supergenerics Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Lasa Supergenerics Ltd disclose current and historical energy intensity?
Does Lasa Supergenerics Ltd report the average age of the workforce?
Does Lasa Supergenerics Ltd reference operational or capital allocation in relation to climate change?
Does Lasa Supergenerics Ltd disclose its ethnicity pay gap?
Does Lasa Supergenerics Ltd disclose cybersecurity risks?
Does Lasa Supergenerics Ltd offer flexible work?
Does Lasa Supergenerics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Lasa Supergenerics Ltd disclose the number of employees in R&D functions?
Does Lasa Supergenerics Ltd conduct supply chain audits?
Does Lasa Supergenerics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Lasa Supergenerics Ltd conduct 360 degree staff reviews?
Does Lasa Supergenerics Ltd disclose the individual responsible for D&I?
Does Lasa Supergenerics Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Lasa Supergenerics Ltd disclose current and / or historical scope 2 emissions?
Does Lasa Supergenerics Ltd disclose water use targets?
Does Lasa Supergenerics Ltd have careers partnerships with academic institutions?
Did Lasa Supergenerics Ltd have a product recall in the last two years?
Does Lasa Supergenerics Ltd disclose incidents of discrimination?
Does Lasa Supergenerics Ltd allow for Work Councils/Collective Agreements to be formed?
Has Lasa Supergenerics Ltd issued a profit warning in the past 24 months?
Does Lasa Supergenerics Ltd disclose parental leave metrics?
Does Lasa Supergenerics Ltd disclose climate scenario or pathway analysis?
Does Lasa Supergenerics Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Lasa Supergenerics Ltd disclose the pay ratio of women to men?
Does Lasa Supergenerics Ltd support suppliers with sustainability related research and development?
Does Lasa Supergenerics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Lasa Supergenerics Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Lasa Supergenerics Ltd involved in embryonic stem cell research?
Does Lasa Supergenerics Ltd disclose GHG and Air Emissions intensity?
Does Lasa Supergenerics Ltd disclose its waste policy?
Does Lasa Supergenerics Ltd report according to TCFD requirements?
Does Lasa Supergenerics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Lasa Supergenerics Ltd disclose energy use targets?
Does Lasa Supergenerics Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Lasa Supergenerics Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Lasa Supergenerics Ltd
These potential risks are based on the size, segment and geographies of the company.
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol; and other API products, such as anthelmintics. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use comprising potassium iodide. It also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.